Apparent mineralocorticoid excess syndrome
|Apparent mineralocorticoid excess syndrome|
|Classification and external resources|
Apparent mineralocorticoid excess (AME) is an autosomal recessive disorder causing hypertension (high blood pressure) and hypokalemia (abnormally low levels of potassium). The condition responds to glucocorticoid treatment. It results from mutations in the HSD11B2 gene, which encodes the kidney isozyme of 11β-hydroxysteroid dehydrogenase type 2. In an unaffected individual, this isozyme inactivates circulating cortisol to the less-active metabolite cortisone. The inactivating mutation leads to elevated local concentrations of cortisol in the kidney. Cortisol at high concentrations can cross-react and activate the mineralocorticoid receptor, leading to aldosterone-like effects in the kidney. This is what causes the hypokalemia, hypertension, and hypernatremia associated with the syndrome.
Other conditions such as Liddle's Syndrome can mimic the clinical features of AME, so diagnosis can be made by calculating the ratio of free urinary cortisol to free urinary cortisone. Since AME patients create less cortisone, the ratio will much be higher than non-affected patients. Alternatively, one could differentiate between the two syndromes by administering a potassium-sparing diuretic. Patients with Liddle's syndrome will only respond to a diuretic that binds the ENaC channel, whereas those with AME will respond to a diuretic that binds to ENaC or the mineralcorticoid receptor.
Liquorice consumption may also cause a temporary form of AME due to its ability to block 11β-hydroxysteroid dehydrogenase type 2, in turn causing increased levels of cortisol. Cessation of licorice consumption will reverse this form of AME.
AME is inherited in an autosomal recessive manner. This means the defective gene responsible for the disorder is located on an autosome, and two copies of the defective gene (one inherited from each parent) are required in order to be born with the disorder. The parents of an individual with an autosomal recessive disorder both carry one copy of the defective gene, but usually do not experience any signs or symptoms of the disorder.
- Inborn errors of steroid metabolism
- 11β-Hydroxylase I deficiency
- Glucocorticoid-remediable aldosteronism
- Aldosterone and aldosterone synthase
- Maria New
- Levtchenko, E. N.; Deinum, J.; Knoers, N. V.; Hermus, A. R.; Monnens, L. A.; Lenders, J. W. (Mar 2007). "From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids". Nederlands tijdschrift voor geneeskunde. 151 (12): 692–694. PMID 17447595.
- Palermo M, Quinkler M, Stewart PM (Oct 2004). "Apparent mineralocorticoid excess syndrome: an overview.". Arq Bras Endocrinol Metabol. 48 (5): 687–696. doi:10.1590/S0004-27302004000500015. PMID 15761540.
- Weizmann Institute of Science > GeneCards > hydroxysteroid (11-beta) dehydrogenase 2 Archived June 2, 2011, at the Wayback Machine. Retrieved on Feb 27, 2010. Cite: Consumption of large amounts of liquorice can lead to apparent mineralocorticoid excess and hypertension